S.T. Stent
Short-term Nasal Stent Technology
StartupS.T. Stent is a startup in the Health Tech & Life Sciences sector, established in 2013. Short-term Nasal Stent Technology. The company has raised a total of $1.76M across 4 funding rounds, currently at the Seed stage. S.T. Stent was founded by Joseph Flomenblit. Key investors include Katao Venture Partners, ExitValley, The Trendlines Group, among 4 total investors. The company has 1-10 employees. Core technologies: Materials & Substances, Implants.
With $1.76M in total funding, S.T. Stent is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageSeed
- ProductReleased
- ModelB2B
- Employees1-10
- HQMisgav, Israel
- Last RoundUndisclosed
- Katao Venture PartnersLead
- ExitValley
- The Trendlines Group
4 investors total
Joseph FlomenblitFounder & CEO
5 articles covered by sources including www.jpost.com,
www.medgadget.com,
www.timesofisrael.com,
www.prnewswire.com.
What does S.T. Stent do?
S.T. Stent develops a composite, removable sinus stent designed to be placed in the ethmoid sinus following functional endoscopic sinus surgery to keep the cavity open for up to 28 days. The stent improves patient outcomes and reduces the probability of revision surgeries. The S.T. Stent adapts to the patients anatomy and does not irritate the tissue or migrate. It provides strong, stable support for the sinus walls and is made from biocompatible materials. The stent can be easily removed at any time in a minimally invasive procedure performed in the doctors office without the need for anesthesia. In 2018 the company was awarded FDA clearance for its sinus stent. S.T. Stent is part of the Trendlines Medical portfolio.
How much funding has S.T. Stent raised?
S.T. Stent has raised $1.76M in total funding across 4 rounds. The company is currently at the Seed stage. Key investors include Katao Venture Partners, ExitValley, The Trendlines Group.
Who founded S.T. Stent?
S.T. Stent was founded in 2013 by Joseph Flomenblit (Founder & CEO).
What sector is S.T. Stent in?
S.T. Stent operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is S.T. Stent located?
S.T. Stent is based in Misgav, Israel.